| Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study D Kim, N Adeniji, N Latt, S Kumar, PP Bloom, ES Aby, P Perumalswami, ... Clinical Gastroenterology and Hepatology 19 (7), 1469-1479. e19, 2021 | 212 | 2021 |
| Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID‐19): US multicenter experience A Rabiee, B Sadowski, N Adeniji, PV Perumalswami, V Nguyen, A Moghe, ... Hepatology 72 (6), 1900-1911, 2020 | 78 | 2020 |
| Impact of exposure to patients with COVID-19 on residents and fellows: an international survey of 1420 trainees AL Cravero, NJ Kim, LD Feld, K Berry, A Rabiee, N Bazarbashi, S Bassin, ... Postgraduate medical journal 97 (1153), 706-715, 2021 | 66 | 2021 |
| Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices TS Dong, A Kalani, ES Aby, L Le, K Luu, M Hauer, R Kamath, KD Lindor, ... Clinical Gastroenterology and Hepatology 17 (9), 1894-1901. e1, 2019 | 65 | 2019 |
| Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver … GY Im, JL Mellinger, A Winters, ES Aby, Z Lominadze, J Rice, MR Lucey, ... Clinical Gastroenterology and Hepatology 19 (11), 2407-2416. e8, 2021 | 64 | 2021 |
| Mutations in palmitoyl-protein thioesterase 1 alter exocytosis and endocytosis at synapses in Drosophila larvae E Aby, K Gumps, A Roth, S Sigmon, SE Jenkins, JJ Kim, NJ Kramer, ... Fly 7 (4), 267-279, 2013 | 37 | 2013 |
| Frailty, sarcopenia, and malnutrition in cirrhotic patients ES Aby, S Saab Clinics in liver disease 23 (4), 589-605, 2019 | 35 | 2019 |
| Barriers to follow-up colonoscopies for patients with positive results from fecal immunochemical tests during colorectal cancer screening FP May, EM Yano, D Provenzale, J Brunner, C Yu, J Phan, P Bharath, ... Clinical Gastroenterology and Hepatology 17 (3), 469-476, 2019 | 34 | 2019 |
| Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease K Wijarnpreecha, ES Aby, A Ahmed, D Kim Clinical and molecular hepatology 27 (2), 221, 2021 | 32 | 2021 |
| Pretransplant sarcopenia in patients with NASH cirrhosis does not impact rehospitalization or mortality ES Aby, E Lee, SS Saggi, MR Viramontes, JF Grotts, VG Agopian, ... Journal of clinical gastroenterology 53 (9), 680-685, 2019 | 29 | 2019 |
| Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity K Wijarnpreecha, P Panjawatanan, E Aby, A Ahmed, D Kim Maturitas 124, 48-54, 2019 | 27 | 2019 |
| Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the United States NJ Kim, K Rozenberg-Ben-Dror, DA Jacob, NE Rich, AG Singal, ES Aby, ... Clinical Gastroenterology and Hepatology 20 (1), 183-193, 2022 | 21 | 2022 |
| Inverse association between chronic hepatitis B infection and coronavirus disease 2019 (COVID-19): Immune exhaustion or coincidence? CM Anugwom, ES Aby, JD Debes Clinical Infectious Diseases 72 (1), 180-182, 2021 | 20 | 2021 |
| Immune Checkpoint Inhibitor Therapy Before Liver Transplantation—Case and Literature Review ES Aby, JR Lake Transplantation Direct 8 (4), e1304, 2022 | 18 | 2022 |
| Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c TS Dong, ES Aby, JN Benhammou, J Kawamoto, SH Han, FP May, ... World journal of hepatology 10 (9), 612, 2018 | 18 | 2018 |
| Inadequate hepatocellular carcinoma screening in patients with nonalcoholic steatohepatitis cirrhosis E Aby, J Phan, E Truong, J Grotts, S Saab Journal of clinical gastroenterology 53 (2), 142-146, 2019 | 17 | 2019 |
| Impact of sustained virologic response on chronic kidney disease progression in hepatitis C ES Aby, TS Dong, J Kawamoto, JR Pisegna, JN Benhammou World Journal of Hepatology 9 (36), 1352, 2017 | 17 | 2017 |
| Association between sarcopenic obesity and nonalcoholic fatty liver disease and fibrosis detected by Fibroscan K Wijarnpreecha, ES Aby, A Ahmed, D Kim J Gastrointestin Liver Dis 30 (2), 227-32, 2021 | 16 | 2021 |
| Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma JN Benhammou, ES Aby, G Shirvanian, K Manansala, SK Hussain, ... Scientific reports 10 (1), 9902, 2020 | 16 | 2020 |
| Proton pump inhibitors and mortality in individuals with COVID-19 ES Aby, H Rodin, JD Debes Official journal of the American College of Gastroenterology| ACG 115 (11), 1918, 2020 | 15 | 2020 |
